Venue: Mærsk Tower, Jens J. Holst Auditorium, Blegdamsvej 3B, 2200 Copenhagen N
Time: 15:30 - 17:00
The Consulate General of Denmark in Houston in collaboration with Texas Medical Center (TMC) are visiting Denmark to sign a formal BioBridge agreement between Denmark and TMC to collaborate on research, innovation and commercialization.
At this event, Danish companies and startups have the opportunity to learn about TMC, the world’s largest medical city, with more than 60 hospitals and medical institutions. Companies with innovative life science technologies focused in digital & tele-health, medical devices and hospital operations have the opportunity to network with TMC representatives. Select Danish startups will pitch to be considered for the TMCx Accelerator program for which Denmark has secured a spot as part of the BioBridge agreement. Subject to application and acceptance by the program.
Who should Attend?
Startups with innovative life science technologies focused in digital & tele-health, medical devices and hospital operations. Health cluster leads and industry representatives and investors.
The Texas-Denmark BioBridge
The Texas Medical Center (TMC) and the Kingdom of Denmark are creating a global life science BioBridge to advance commercial and clinical innovation and to enable research collaborations and knowledge transfer. The BioBridge is bringing together government, academic and research institutions, and innovation organizations to collaborate in two areas: 1) innovation and commercialization and 2) research and education.
Tom Luby, Ph.D., Head TMC Innovation. Tom Luby Ph.D. is the Director of Texas Medical Center (TMC) Innovation. In this role, he oversees all of the innovation efforts of TMC focused on research, education, and commercialization of novel healthcare solutions. Prior to this, he was the head of JLABS @ TMC in Houston, Texas. In that role, he catalyzes and support the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device and consumer healthcare sectors.
Tom started at Johnson & Johnson Innovation as a New Ventures Lead at the Johnson & Johnson Innovation Center in Boston. In that role, he was instrumental in fostering many deals for the Boston office, which included the expansion of JLABS to JLABS @ Toronto. Prior to J&J, Tom spent 14 years in various R&D and business development positions, most recently as Sr. Director, Research Ventures at Shire. Nine of those years were spent working in R&D and operational roles across three start-up biotech companies in the Boston area.
Tom received a Bachelor of Science in Biology from State University of New York, and a Ph.D. in Immunology from the Sackler School of Biomedical Sciences at Tufts University.
Lance Black, MD, MBID is the Associate Director of the Texas Medical Center’s TMCx Accelerator program. Dr. Black served previously as Medical Device Innovation Lead, and draws on his extensive military, medical, and engineering expertise to support the resident companies of TMCx in developing innovative healthcare technologies.
After earning his B.S. in Biological Engineering from Louisiana State University and his M.D. from LSU Health Sciences Center of New Orleans, Dr. Black served in the U.S. Air Force and deployed overseas twice: first as Chief of Medical Staff for Manas Transit Base in Kyrgyzstan, and then as a Squadron Flight Surgeon in Okinawa, Japan. During his time in the armed forces, Dr. Black helped to create modular medical facilities for civilian use, and designed and implemented safety protocols for F-22 stealth fighter pilots and their crews.
Inspired from his work with Wounded Warrior amputees, Dr. Black utilized his background in Biological Engineering to focus on the design and development of medical devices. Following his exit from service, Dr. Black received his Masters of Biomedical Innovation & Development from Georgia Tech, including a year in their Masters of Industrial Design program.
Habib Frost, MD, Founder & CEO of Neurescue. Youngest Medical Doctor in Denmark at age 23. Inventor of Neurescue’s patents. Certified Trauma Team Leader. Forbes 30 under 30 and MIT innovators under 35.
Trine Winterøe, PhD is Vice Dean for Innovation and External Relations at the Faculty of Health and Medical Sciences, University of Copenhagen (UCPH). In close collaboration with scientists and researchers at UCPH, she works on building an infrastructure that supports processes around innovation and commercialization of research. Prior to joining UCPH, Trine has extended experience in the medtech and life science being the CEO of the MedTech Innovation Center in Aarhus, and from leadership positions in technology transfer and early stage venture capital. In addition, Trine serves on several boards, and is an active member of various both public and private innovation groups.